These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3307118)

  • 21. New approaches to vaccine development: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(3):479-84. PubMed ID: 3876169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approaches in vaccine development for parasitic infections.
    Tarleton RL
    Cell Microbiol; 2005 Oct; 7(10):1379-86. PubMed ID: 16153238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Traditional and innovative diagnostic tools: when and why they should be applied].
    Cancrini G; Iori A
    Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA vaccines and their application against parasites--promise, limitations and potential solutions.
    Smooker PM; Rainczuk A; Kennedy N; Spithill TW
    Biotechnol Annu Rev; 2004; 10():189-236. PubMed ID: 15504707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA vaccines against tropical parasitic diseases.
    Da'dara AA; Harn DA
    Expert Rev Vaccines; 2005 Aug; 4(4):575-89. PubMed ID: 16117713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards molecular vaccines against parasites.
    Mitchell GF
    Parasite Immunol; 1984 Nov; 6(6):493-8. PubMed ID: 6522094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA vaccines: a review of developments.
    Webster RG; Robinson HL
    BioDrugs; 1997 Oct; 8(4):273-92. PubMed ID: 18020519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biotechnology and animal health].
    Desmettre P
    Rev Sci Tech; 1993 Jun; 12(2):355-68. PubMed ID: 8400382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans.
    Cunha-Neto E
    Braz J Med Biol Res; 1999 Feb; 32(2):199-205. PubMed ID: 10347755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parasite vaccines: the new generation.
    Crampton A; Vanniasinkam T
    Infect Genet Evol; 2007 Sep; 7(5):664-73. PubMed ID: 17702669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edible vaccines against veterinary parasitic diseases--current status and future prospects.
    Jacob SS; Cherian S; Sumithra TG; Raina OK; Sankar M
    Vaccine; 2013 Apr; 31(15):1879-85. PubMed ID: 23485715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine Trials for the Clinician: Prospects for Tumor Antigens.
    Osanto S
    Oncologist; 1997; 2(5):284-299. PubMed ID: 10388061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory T-cell subsets in parasitic infections.
    Colpitts S; Scott P
    Adv Exp Med Biol; 2010; 684():145-54. PubMed ID: 20795546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in the development of recombinant and synthetic blood-stage malaria vaccines.
    Mahanty S; Saul A; Miller LH
    J Exp Biol; 2003 Nov; 206(Pt 21):3781-8. PubMed ID: 14506213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity.
    Speiser DE; Romero P
    Semin Immunol; 2010 Jun; 22(3):144-54. PubMed ID: 20413326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic glycans in parasitic infections: implications for vaccines and diagnostics.
    Nyame AK; Kawar ZS; Cummings RD
    Arch Biochem Biophys; 2004 Jun; 426(2):182-200. PubMed ID: 15158669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.